Complement C4 Phenotypes in Patients with End-stage Renal Disease
Overview
Affiliations
The phenotypes of complement C4 were determined by agarose gel electrophoresis in 130 patients with end-stage renal failure of various causes and compared with those of 140 healthy controls. C4 allotype frequencies did not differ between patients and controls. Null alleles of both isotypes C4A and C4B were increased, but also without reaching significance. In type 1 diabetics an increased frequency of C4AQ0 (25 vs. 11.8%, p < 0.05) was found. Patients with two null alleles were far more frequent in the group with insulin-dependent diabetes mellitus (25 vs. 3.6%, p < 0.01). We confirmed the presence of a previously described uremic variant of C4B1. Additional uremic variants of C4 were detected in uremic patients homozygous for C4A3, B2 and B3. The relative electrophoretic migration values of the uremic variants of C4A3, B1, B2 and B3 were 132.1 +/- 2.9, 35.8 +/- 1.5, 70.4 and 73.9. These variants appear early in the course of chronic renal failure and disappear after successful renal transplantation. Uremic variants are the only acquired C4 phenotypes known so far. How uremia causes these variants remains unclear, but probably involves carbamylation of the C4 molecule.
Freiwald T, Afzali B Adv Immunol. 2021; 152:1-81.
PMID: 34844708 PMC: 8905641. DOI: 10.1016/bs.ai.2021.09.001.
Kalim S, Berg A, Karumanchi S, Thadhani R, Allegretti A, Nigwekar S Nephrol Dial Transplant. 2021; 37(1):139-147.
PMID: 33661286 PMC: 8719615. DOI: 10.1093/ndt/gfaa347.
Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.
Kalim S, Tamez H, Wenger J, Ankers E, Trottier C, Deferio J Clin J Am Soc Nephrol. 2013; 8(11):1927-34.
PMID: 23970130 PMC: 3817911. DOI: 10.2215/CJN.04310413.